Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:17 AM
Ignite Modification Date:
2025-12-25 @ 2:17 AM
NCT ID:
NCT01282060
Eligibility Criteria:
Inclusion Criteria:
* Patient with type 2 diabetes, aged 70 and over,
* Patient having received medicinal or non-medicinal treatment (in the case of diabetics treated with insulin, the length of time between diagnosis of diabetes and the onset of insulin therapy will be at least 2 years),
* Diabetes diagnosed for at least one year,
* Patient with autonomy defined by a score greater than or equal to 3/6 on the ADL scale,
* Patient who can be monitored during hospital or private consultations over the next 10 years,
* Patient who did not refuse to take part in the study after receiving information on the study (Patient Information Leaflet), Patients are monitored in the hospital or private sector throughout France.
Exclusion Criteria:
* Patient with type 1 diabetes,
* Patient with secondary diabetes (mainly corticosteroid-induced),
* Patient with a loss of autonomy defined by a score of less than 3/6 on the ADL scale,
* Patient who cannot be monitored in the months or years to come,
* Patient in an acute situation (transient exclusion criterion),
* Patient expressing their refusal to participate in the study.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
70 Years
Study:
NCT01282060
Study Brief:
Protocol Section:
NCT01282060